33-week non-inferiority of extended- vs. immediate-release pramipexole tablets in treatment of early Parkinson's disease

被引：0

作者：

Poewe, W. ^{[1
]}

Barone, P. ^{[2
]}

Hauser, R. ^{[3
]}

Mizuno, Y. ^{[4
]}

Rascol, O. ^{[5
]}

Schapira, A. ^{[6
]}

Haaksma, M. ^{[7
]}

Salin, L. ^{[8
]}

机构：

[1] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria

[2] Univ Naples Federico 2, Dept Neurol Sci, I-80138 Naples, Italy

[3] Univ S Florida, Parkinsons Dis & Movement Disorders Ctr, Tampa, FL USA

[4] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan

[5] Toulouse Univ Hosp, INSERM, Clin Invest Ctr, Toulouse, France

[6] Inst Neurol, Univ Dept Clin Neurosci, London WC1N 3BG, England

[7] Boehringer Ingelheim Pharma RCV GmbH & Co KG, Vienna, Austria

[8] Boehringer Ingelheim France SAS, Reims, France

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：28 / 28

页数：1